Long-term effect of early intervention with single intravitreal injection of bevacizumab followed by panretinal and macular grid photocoagulation in central retinal vein occlusion (CRVO) with macular edema: A pilot study

Eye

Volumn 25, Issue 2, 2011, Pages 239-244

  Shah, N J ^a   Shah, U N ^a  

^a Eye Super Specialties   (India)

Author keywords

bevacizumab; central retinal vein occlusion; intravitreal injection; macular edema; panretinal photocoagulation; vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LASER COAGULATION; MALE; PAPILLEDEMA; PILOT STUDY; PROSPECTIVE STUDY; RETINA HEMORRHAGE; RETINA MACULA EDEMA; SINGLE DRUG DOSE; TREATMENT OUTCOME; VEIN DILATATION; VISUAL ACUITY;

EID: 79951560006     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.225     Document Type: Article

References (17)

1. Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology 1990; 90: 481-483.
2. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systemat (Pubitemid 46282974)
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487. (Pubitemid 24356306)
4. Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26: 279-284. (Pubitemid 44318180)
5. Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK et al. Clinical, anatomic and electrophysiologic evaluation evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-606.
6. Spandau UH, Ihloff AK, Jonas JB. Intravitreal bevacizumab treatment of macular edema due to central retinal vein occlusion. Acta Ophthalmol Scand 2006; 84: 555-556. (Pubitemid 44109048)
7. Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1429-1436. (Pubitemid 47423323)
8. Rensch F, Jonas JB, Spandau UH. Early intravitreal bevacizumab for non-ischemic central retinal vein occlusion. Acta Ophthalmologica 2009; 87: 77-81.
9. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007; 144: 864-871. (Pubitemid 350122344)
10. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: The Central Vein occlusion Study Group N report. Ophthalmology 1995; 102: 1434-1444.
11. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology 1995; 102: 1425-1433.
12. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. Bevacizumab plus irinotecan,fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342. (Pubitemid 38702844)
13. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 336-339. (Pubitemid 41073113)
14. Kaiser RS, Sivalingam A, Abraham P, Abraham P, Fineman MS, Samuel MA et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina 2007; 27: 1013-1019. (Pubitemid 350304000)
15. The Central Vein Occlusion Study Group. Natural history and clinical management of Central Retinal vein Occlusion. Arch Ophthalmol 1997; 115: 486-491.
16. Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007; 27: 426-431. (Pubitemid 46624281)
17. Takahashi K, Muraoka K, Kishi S, Shimizu K. Formation of retinochoroidal collaterals in central retinal vein occlusion. Am J Ophthalmol 1998; 126: 91-99. (Pubitemid 28341223)